Tag: NASDAQ:APTO

July 8, 2019

5 Top Biotech Stocks on the TSX Year-to-Date

Which biotech stocks on the TSX have performed the best so far in 2019? Here's a look at the five...
June 6, 2019

VIDEO — US vs. Canada Healthcare Systems: Is One Better?

INN asked four company CEOs their thoughts on the US and Canadian healthcare systems and whether one is better than...
May 16, 2019

VIDEO Round-Up BBHIC 2019

BBHIC is over for another year. In case you missed it, here's a compilation of all INN's video interviews from...
May 13, 2019

VIDEO — Aptose Biosciences CEO: Clinical Programs in the Works

William Rice of Aptose Biosciences discusses the company's two clinical programs and a drug candidate in the discovery stage.
May 1, 2019

BBHIC 2019, Day 2: Notes From the Floor

The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.
March 25, 2019

Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806

Aptose Biosciences (NASDAQ:APTO,TSX:APS) has announced that the US Food and Drug Administration (FDA) has completed its review of Aptose Bioscience’s...
November 4, 2018

5 Top Weekly NASDAQ Biotech Stocks: Aptose Leads this Week

Aptose Biosciences, Trevena, Curis, Geron and Aveo Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.